Compare Neurocrine Biosciences Inc (NBIX) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Tenet Healthcare Corporation — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Tenet Healthcare Corporation trades at $196.03 (market cap $16.74B). The key difference: Neurocrine Biosciences Inc and Tenet Healthcare Corporation are close in size by market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals.
| NBIX | THC | |
|---|---|---|
Market Cap | $17.40B | $16.74B |
Sector | Health | Health |
52-Week High | $180.55 | $244.80 |
52-Week Low | $123.10 | $148.38 |
Enterprise Value | $16.49B | $26.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
